The Archer Report found that "The United Kingdom delayed testing until a specific test (as opposed to a surrogate test) became available. Even then, although such a test was in use in Japan in 1989, and in the USA, Australia and most European countries in 1990, the United Kingdom delayed introduction until the product had been approved by the Food and Drug Administration (FDA) in the USA, and it was not introduced into the United Kingdom until September 1991."